Results 31 to 40 of about 78 (77)

Изучение эффектов инъекционной формы гимантана на экспериментальных моделях паркинсонического синдрома

Фармакокинетика и Фармакодинамика, 2012
Гимантан в инъекционной лекарственной форме при различных способах однократного и субхронического парентерального введения проявляет позитивный дозозависимый эффект на различных экспериментальных моделях паркинсонического синдрома.

doaj  

[Characteristics of geriatric and somatic status in patients with osteoporosis]. [PDF]

Probl Endokrinol (Mosk), 2021
Khovasova NO, Naumov AV, Tkacheva ON, Dudinskaya EN.   +3 more
europepmc   +1 more source

[Testosterone and Alzheimer's disease]. [PDF]

Probl Endokrinol (Mosk), 2022
Kuznetsov KO, Khaidarova RR, Khabibullina RH, Stytsenko ES, Filosofova VI, Nuriakhmetova IR, Hisameeva EM, Vazhorov GS, Khaibullin FR, Ivanova EA, Gorbatova KV.   +10 more
europepmc   +1 more source

[The role of antidiabetic drugs in the treatment of Alzheimer's disease: systematic review]. [PDF]

Probl Endokrinol (Mosk), 2023
Ishmuratova AN, Abramov MA, Kuznetsov KO, Ivanyuta MV, Shakirova ZF, Kitapova AI, Usmonov MD, Chernousova LM, Valeeva LI, Kuznetsova AY, Baislamov AS, Shaihetdinova AR, Mirgaliev AA, Orozberdiev ST, Yakupova KI.   +14 more
europepmc   +1 more source

Chemical destruction of vestibular receptors, as a method of neuromodulation for the treatment of neurological and mental symptoms of Parkinson’s disease

Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018
In work the modern view on questions of an etiology and pathogenesis of neurodegenerate diseases and in particular is provided to Parkinson’s disease. Outstanding performance of a method of a chemical destruction of vestibular receptors (CDVR) in case of
A. G. Naryshkin, I. V. Galanin, A. L. Gorelik, T. A. Skoromets, Y. O. Vikhreva   +4 more
doaj  

Development of a neural network for diagnosing the risk of depression according to the experimental data of the stop signal paradigm. [PDF]

Vavilovskii Zhurnal Genet Selektsii, 2022
Zelenskih MO, Saprygin AE, Rudych PD, Lebedkin DA, Savostyanov AN.   +4 more
europepmc   +1 more source

Pharmacoeconomic evaluation of pramipexole extended release monotherapy in early Parkinson’s disease

Качественная клиническая практика, 2018
Objective. Health economic expertise of pramipexole extended release monotherapy at early stages of Parkinson’s disease. Methods. An economic model was developed based on clinical studies to derive comparative information on the effectiveness, utility ...
D. Yu. Belousov, E. V. Afanasyeva
doaj  

[Effect of bone anabolic therapy on bone remodeling and bone density in geriatric patients with osteoporosis and falling syndrome]. [PDF]

Probl Endokrinol (Mosk), 2022
Khovasova NO, Dudinskaya EN, Naumov AV, Tkacheva ON, Machekhina LV, Onuchina JS.   +5 more
europepmc   +1 more source

Quantifying human genome parameters in aging. [PDF]

Vavilovskii Zhurnal Genet Selektsii, 2023
Volobaev VP, Kunizheva SS, Uralsky LI, Kupriyanova DA, Rogaev EI.   +4 more
europepmc   +1 more source

[The ketogenic diet: history, mechanism of action, indications and contraindications]. [PDF]

Probl Endokrinol (Mosk), 2021
Ivannikova EV, Altashina MA, Troshina EA.   +2 more
europepmc   +1 more source